Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
17.2M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
+2.82M
-
Total reported value, excl. options
-
$142M
-
Value change
-
+$30.1M
-
Number of buys
-
18
-
Number of sells
-
-9
-
Price
-
$10.27
Significant Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) as of Q2 2025
40 filings reported holding TDAC - Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share as of Q2 2025.
Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 17.2M outstanding shares and own 80.95% of the company stock.
Largest 10 shareholders include WOLVERINE ASSET MANAGEMENT LLC (1.35M shares), Magnetar Financial LLC (1.3M shares), AQR Arbitrage LLC (1.1M shares), LMR Partners LLP (800K shares), Hudson Bay Capital Management LP (650K shares), First Trust Capital Management L.P. (650K shares), TENOR CAPITAL MANAGEMENT Co., L.P. (635K shares), Karpus Management, Inc. (617K shares), Polar Asset Management Partners Inc. (600K shares), and Linden Advisors LP (600K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.